Regulators of Breast Cancer Metastasis

A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Metastasis".

Deadline for manuscript submissions: 30 June 2025 | Viewed by 4138

Special Issue Editors


E-Mail Website
Guest Editor
Biomedical Sciences Graduate Program, University of California, San Francisco, CA, USA
Interests: chromatin organization; genome organizers; DNA structure; transcriptional regulation; epigenetics; cancer metastasis; cancer treatment; cancer diagnosis and prognosis; development

E-Mail Website
Guest Editor
Department of Medicine, Case Western Reserve University, Cleveland, OH, USA
Interests: tumor microenvironment; tumor immunity; immunotherapy; metabolism; microbiome

Special Issue Information

Dear Colleagues,

Targeted therapies for breast cancer have made major advances in recent years. Some therapies known as antibody-drug conjugates can prolong survival of late-stage breast cancer on average of 6-month improvement in prolongation compared to traditional chemotherapy alone. Despite the significant improvement in therapies, metastasis is still the major cause of death from cancer and metastatic breast cancer remains the second leading cause of cancer-associated death of women in the United States. Although breast cancer is known to be a highly heterogeneous disease, it remains true that cancer undergoes progression with time and many acquire the metastatic phenotypes eventually despite the treatment. Therefore, it is important to understand more deeply about the regulatory mechanisms underlying the metastatic phenotypes so that in the future, more effective therapies can be developed to prevent or inhibit cancer progression toward metastasis and recurrence.  In this issue, we aim to address regulation of breast cancer metastasis from broad angles, such as key molecules (e.g. proteins, non-coding RNAs, chemicals), epigenetic and transcriptional regulators, signaling pathways, extracellular environment at primary site (i.e., tumor microenvironment) and distant metastasis site (i.e., metastatic niche), metabolism, immunity, microbiome and aging. Technologies to identify regulators and mechanisms underlying cancer progression are also crucial to develop.  We aim to bring together scientists specialized in different approaches for cancer research in this issue to provide the current perspectives with regards to breast cancer metastasis. We wish to invite review articles and original research studies, focusing on the molecular mechanisms underlying breast cancer progression.

Prof. Dr. Terumi Kohwi-Shigematsu
Dr. Saori Furuta
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • tumor progression regulators
  • metastasis
  • tumor microenvironment
  • biomarkers for recurrence
  • transcriptional regulation
  • chromatin structure
  • epigenetics
  • cancer metabolism
  • cancer immunity
  • microbiome

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Review

26 pages, 1511 KiB  
Review
Microbiome—Stealth Regulator of Breast Homeostasis and Cancer Metastasis
by Saori Furuta
Cancers 2024, 16(17), 3040; https://doi.org/10.3390/cancers16173040 - 31 Aug 2024
Cited by 2 | Viewed by 1561
Abstract
Cumulative evidence attests to the essential roles of commensal microbes in the physiology of hosts. Although the microbiome has been a major research subject since the time of Luis Pasteur and William Russell over 140 years ago, recent findings that certain intracellular bacteria [...] Read more.
Cumulative evidence attests to the essential roles of commensal microbes in the physiology of hosts. Although the microbiome has been a major research subject since the time of Luis Pasteur and William Russell over 140 years ago, recent findings that certain intracellular bacteria contribute to the pathophysiology of healthy vs. diseased tissues have brought the field of the microbiome to a new era of investigation. Particularly, in the field of breast cancer research, breast-tumor-resident bacteria are now deemed to be essential players in tumor initiation and progression. This is a resurrection of Russel’s bacterial cause of cancer theory, which was in fact abandoned over 100 years ago. This review will introduce some of the recent findings that exemplify the roles of breast-tumor-resident microbes in breast carcinogenesis and metastasis and provide mechanistic explanations for these phenomena. Such information would be able to justify the utility of breast-tumor-resident microbes as biomarkers for disease progression and therapeutic targets. Full article
(This article belongs to the Special Issue Regulators of Breast Cancer Metastasis)
Show Figures

Figure 1

15 pages, 990 KiB  
Review
ELF5: A Molecular Clock for Breast Aging and Cancer Susceptibility
by Masaru Miyano and Mark A. LaBarge
Cancers 2024, 16(2), 431; https://doi.org/10.3390/cancers16020431 - 19 Jan 2024
Cited by 1 | Viewed by 2017
Abstract
Breast cancer is predominantly an age-related disease, with aging serving as the most significant risk factor, compounded by germline mutations in high-risk genes like BRCA1/2. Aging induces architectural changes in breast tissue, particularly affecting luminal epithelial cells by diminishing lineage-specific [...] Read more.
Breast cancer is predominantly an age-related disease, with aging serving as the most significant risk factor, compounded by germline mutations in high-risk genes like BRCA1/2. Aging induces architectural changes in breast tissue, particularly affecting luminal epithelial cells by diminishing lineage-specific molecular profiles and adopting myoepithelial-like characteristics. ELF5 is an important transcription factor for both normal breast and breast cancer development. This review focuses on the role of ELF5 in normal breast development, its altered expression throughout aging, and its implications in cancer. It discusses the lineage-specific expression of ELF5, its regulatory mechanisms, and its potential as a biomarker for breast-specific biological age and cancer risk. Full article
(This article belongs to the Special Issue Regulators of Breast Cancer Metastasis)
Show Figures

Figure 1

Back to TopTop